TXG10x Genomics, Inc.

$80.64+518% 1Y

What is the market doing?

Mixed

No clear lean: in an uptrend, but heavily shorted (+13% of shares).

1 good, 1 to watch, 1 neutral
TrendUptrendderived · Oct 9, 2026

In an uptrend, above its rising 50- and 200-day averages. Price is +132% vs its 200-day average.

Insider conviction−$12.2M (90 days to Oct 8, 2026)SEC EDGAR · Oct 8, 2026

Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).

Short interest13% of sharesFINRA · Sep 15, 2026

Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returntop 1% of the market
vs 200-day avgtop 1% of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How TXG is trading

10x Genomics, Inc. is +518% over the past year while the S&P 500 is +18%: 500 points ahead of the market.

+518%

1-year return · S&P 500 +18%

vs 200-day average
+132%

vs 200-day average · a clear uptrend

RSI (14)
51

RSI (14) · neutral

Below its 52-week high
18%

Below its 52-week high

Sep 18, 2024$7.14 – $97.82 · dashed line: 200-day averageOct 9, 2026
Details›
Last close2026-10-09
$80.64
1 monthS&P 500 +2.7%
+22%
1 yearS&P 500 +18%
+518%
5 yearsS&P 500 +88%
−48%
vs 50-day average$67.97
+19%
52-week high
$97.81
52-week low
$11.34
Annualised volatility
74%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
−$6.2M
Calendar-year price return
YearReturn
2026 (year to date)+394%
2025+14%
2024−74%
2023+54%
2022−76%
2021+5.2%
2020+86%
Average return by calendar month, 2019–2026
MonthYearsPositiveAverage
Jan75 of 7+5.2%
Feb74 of 7−3.6%
Mar72 of 7−7.9%
Apr73 of 7−4.2%
May74 of 7+2.3%
Jun75 of 7+7.5%
Jul75 of 7+8.5%
Aug74 of 7+3.8%
Sep72 of 7−2.5%
Oct84 of 8−0.81%
Nov75 of 7+17%
Dec72 of 7+1.0%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.

On our screens:Most shorted stocks